The Irving Institute Joins the Action Collaborative on Countering the U.S. Opioid Epidemic

The National Academy of Medicine (NAM) announced that more than 100 organizations across the U.S. — including community organizations, hospital and medical systems, academia, nonprofits, and health professional societies — have joined NAM in declaring their commitment to reversing national trends in opioid misuse and overdose. The announcement was made at a meeting of the NAM’s Action Collaborative on Countering the U.S. Opioid Epidemic.

To provide an opportunity for organizations to discuss and share plans of action, the NAM recently called for and has collected statements describing current work and future goals to counter the opioid epidemic in the areas of health professional education and training; opioid prescribing guidelines and evidence standards; prevention, treatment, and recovery; and research, data, and metrics.

By making a visible commitment to combating the opioid crisis, these groups join the action collaborative as network organizations. The full list of organizations is available at nam.edu/OpioidNetworkOrgs. 

The Irving Institute for Clinical and Translational Research’s response to the opioid crisis was first stimulated by Dr. Christopher Austin, (Director of the National Center for Advancing Translational Sciences (NCATS)) and his call-to-action to address the opioid crisis during the October 2017 meeting of all Clinical and Translational Science Award (CTSA) Program hubs.

For updates and more information, see our Opioid Crisis Response page.